Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 139

1.

Risk factors for radiation exposure in newly diagnosed IBD patients.

Grand DJ, Harris A, Shapiro J, Wu E, Giacalone J, Sands BE, Bright R, Moniz H, Mallette M, Leleiko N, Wallenstein S, Samad Z, Merrick M, Shah SA.

Abdom Radiol. 2016 Jan 27. [Epub ahead of print]

PMID:
26814500
2.

Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: a Propensity Score Analysis.

Choshen S, Finnamore H, Auth MK, Bdolah-Abram T, Shteyer E, Mack D, Hyams J, Leleiko N, Griffiths A, Turner D.

J Pediatr Gastroenterol Nutr. 2015 Dec 15. [Epub ahead of print]

PMID:
26756874
3.

Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients.

Shapiro JM, Hagin SE, Shah SA, Bright R, Law M, Moniz H, Giacalone J, Jackvony T, Taleban S, Samad Z, Merrick M, Sands BE, LeLeiko NS.

Dig Dis Sci. 2016 Jan 2. [Epub ahead of print]

PMID:
26725063
4.

Durability of Infliximab is Associated with Disease Extent in Children with Inflammatory Bowel Disease.

Shapiro JM, Subedi S, Machan JT, Cerezo CS, Ross AM, Shalon LB, Silverstein JA, Herzlinger MI, Kasper V, LeLeiko NS.

J Pediatr Gastroenterol Nutr. 2015 Nov 17. [Epub ahead of print]

PMID:
26583483
5.

Adrenal Suppression in EoE Treated With Budesonide?

LeLeiko NS, Quintos JB.

J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):155. doi: 10.1097/MPG.0000000000000877. No abstract available.

PMID:
26222658
6.

Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study.

Townsend P, Zhang Q, Shapiro J, Webb-Robertson BJ, Bramer L, Schepmoes AA, Weitz KK, Mallette M, Moniz H, Bright R, Merrick M, Shah SA, Sands BE, Leleiko N.

Inflamm Bowel Dis. 2015 Aug;21(8):1935-41. doi: 10.1097/MIB.0000000000000445.

PMID:
26199992
7.

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping.

Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, Dubinsky M, Baldassano R, Crandall WV, Rosh J, Markowitz J, Stephens M, Kellermayer R, Pfefferkorn M, Heyman MB, LeLeiko N, Mack D, Moulton D, Kappelman MD, Kumar A, Prince J, Bose P, Mondal K, Ramachandran D, Bohnsack JF, Griffiths AM, Haberman Y, Essers J, Thompson SD, Aronow B, Keljo DJ, Hyams JS, Denson LA; PRO-KIIDS Research Group, Kugathasan S.

PLoS One. 2015 Jun 22;10(6):e0128074. doi: 10.1371/journal.pone.0128074. eCollection 2015.

8.

Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort.

Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Carvalho R, Keljo D, Pfefferkorn M, Faubion W Jr, Kappelman M, Sudel B, Schaefer ME, Markowitz J, Hyams JS.

J Pediatr. 2015 Sep;167(3):527-32.e1-3. doi: 10.1016/j.jpeds.2015.04.045. Epub 2015 May 15.

PMID:
25982142
9.

Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.

Grossi V, Lerer T, Griffiths A, LeLeiko N, Cabrera J, Otley A, Rick J, Mack D, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Boyle B, Oliva-Hemker M, Keljo D, Pfefferkorn M, Faubion W, Kappelman MD, Sudel B, Markowitz J, Hyams JS.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1748-56. doi: 10.1016/j.cgh.2015.04.010. Epub 2015 Apr 21.

PMID:
25911120
10.

Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?

Shapiro JM, Cho JH, Sands BE, LeLeiko NS.

Clin Gastroenterol Hepatol. 2015 May;13(5):842-6. doi: 10.1016/j.cgh.2015.02.028. Epub 2015 Feb 25. Review.

PMID:
25725444
11.

CHD6 regulates the topological arrangement of the CFTR locus.

Sancho A, Li S, Paul T, Zhang F, Aguilo F, Vashisht A, Balasubramaniyan N, Leleiko NS, Suchy FJ, Wohlschlegel JA, Zhang W, Walsh MJ.

Hum Mol Genet. 2015 May 15;24(10):2724-32. doi: 10.1093/hmg/ddv032. Epub 2015 Jan 28.

PMID:
25631877
12.

Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting.

Krishnarao A, de Leon L, Bright R, Moniz H, Law M, Leleiko N, Sands BE, Merrick M, Shapiro J, Wallenstein S, Giacalone J, Shah SA.

Inflamm Bowel Dis. 2015 Mar;21(3):564-9. doi: 10.1097/MIB.0000000000000309.

PMID:
25581825
13.

Body image dissatisfaction in patients with inflammatory bowel disease.

Saha S, Zhao YQ, Shah SA, Esposti SD, Lidofsky S, Shapiro J, Leleiko N, Bright R, Law M, Moniz H, Samad Z, Merrick M, Sands BE.

Inflamm Bowel Dis. 2015 Feb;21(2):345-52. doi: 10.1097/MIB.0000000000000270. Erratum in: Inflamm Bowel Dis. 2015 Apr;21(4):900. Shapiro, Jason [added]; Leleiko, Neal [added].

14.

Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.

Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

Inflamm Bowel Dis. 2014 Aug;20(8):1341-5. doi: 10.1097/MIB.0000000000000102.

PMID:
24983976
15.

Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.

Goyal A, Hyams JS, Lerer T, Leleiko NS, Otley AR, Griffiths AM, Rosh JR, Cabrera JM, Oliva-Hemker MM, Mack DR, Rick JN, Pfefferkorn MD, Carvalho R, Grossman AB, Hitch MC, Sudel B, Kappelman MD, Saeed SA, Faubion WA, Schaefer ME, Markowitz JF, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):321-3. doi: 10.1097/MPG.0000000000000409.

PMID:
24796799
16.

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity.

Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE.

Aliment Pharmacol Ther. 2014 Apr;39(8):811-22. doi: 10.1111/apt.12659. Epub 2014 Feb 20.

17.

Depressive symptoms in youth with inflammatory bowel disease compared with a community sample.

Reed-Knight B, Lobato D, Hagin S, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau JH, Suorsa K, Bancroft B, Shapiro J, Leleiko NS.

Inflamm Bowel Dis. 2014 Apr;20(4):614-21. doi: 10.1097/01.MIB.0000442678.62674.b7.

18.

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE.

Inflamm Bowel Dis. 2014 Feb;20(2):398-415. doi: 10.1097/01.MIB.0000435441.30107.8b. Review.

19.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.

Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group.

Gastroenterology. 2014 Feb;146(2):383-91. doi: 10.1053/j.gastro.2013.10.027. Epub 2013 Oct 23.

PMID:
24162032
20.

6-Thioguanine levels in pediatric IBD patients: adherence is more important than dose.

LeLeiko NS, Lobato D, Hagin S, Hayes C, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau J, Suorsa K, Shapiro J, Bancroft B.

Inflamm Bowel Dis. 2013 Nov;19(12):2652-8. doi: 10.1097/01.MIB.0000436960.00405.56.

PMID:
24105391
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk